Ignite Creation Date:
2025-12-24 @ 5:43 PM
Ignite Modification Date:
2026-01-21 @ 7:35 PM
Study NCT ID:
NCT03364868
Status:
COMPLETED
Last Update Posted:
2024-10-08
First Post:
2017-11-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)
Sponsor:
Technical University of Munich
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diabetes Mellitus, Type 1 | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Type 1 diabetes | View |
| None | T1D | View |
| None | diabetes mellitus | View |
| None | oral insulin | View |
| None | oral tolerance | View |
| None | autoantigen | View |
| None | self tolerance | View |
| None | prevention | View |
| None | at risk for developing type 1 diabetes | View |
| None | juvenile diabetes | View |
| None | autoimmune diabetes | View |